Roche and Chiron both claim victory in HCV (hepatitis C virus) patent dispute
This article was originally published in Clinica
Executive Summary
The long-running battle between Chiron and Roche Diagnostics over patent rights to nucleic acid testing in hepatitis C virus (HCV) diagnostic kits took another turn last week. Chiron gained a win of sorts, when the European Patent Office (EPO) technical appeals board upheld its European HCV patent, 0318216.